NCT03326921
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +63 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Lymphoma
Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.
3,646 public trials
848 recruiting studies
Lymphoma trial results
NCT05976997
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
NCT05355051
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +7 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT06005870
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
NCT06879340
- Conditions
- B-Cell Non-Hodgkin Lymphoma, B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, +16 more
- Locations
-
- University of Kansas Cancer Center Westwood, Kansas, United States
NCT03779854
- Conditions
- Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage, +54 more
- Locations
-
- Children's Hospital of Los Angeles Los Angeles, California, United States
- Children's National Medical Center Washington D.C., District of Columbia, United States
- Children's Healthcare of Atlanta Atlanta, Georgia, United States
- University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
Recruiting
Obinutuzumab, Zanubrutinib, and Lenalidomide in First-line Treatment of Mantle Cell Lymphoma
NCT07261163
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China
- Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
NCT05794880
- Conditions
- Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Anemia, +44 more
- Locations
-
- Children's Wisconsin Milwaukee, Wisconsin, United States
Recruiting
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
NCT05272384
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +15 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Yale University New Haven, Connecticut, United States
NCT07052305
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States